Lmcg Investments LLC cut its stake in Elevance Health, Inc. (NYSE:ELV – Free Report) by 3.0% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 19,401 shares of the company’s stock after selling 597 shares during the period. Lmcg Investments LLC’s holdings in Elevance Health were worth $7,157,000 as of its most recent filing with the Securities & Exchange Commission.
Several other large investors also recently bought and sold shares of ELV. Cypress Wealth Services LLC increased its holdings in shares of Elevance Health by 3.5% in the third quarter. Cypress Wealth Services LLC now owns 679 shares of the company’s stock valued at $353,000 after purchasing an additional 23 shares during the period. Atomi Financial Group Inc. boosted its holdings in shares of Elevance Health by 4.2% in the 3rd quarter. Atomi Financial Group Inc. now owns 615 shares of the company’s stock valued at $320,000 after acquiring an additional 25 shares during the last quarter. Lifeworks Advisors LLC raised its holdings in shares of Elevance Health by 2.5% during the third quarter. Lifeworks Advisors LLC now owns 1,037 shares of the company’s stock worth $539,000 after purchasing an additional 25 shares during the last quarter. Catalyst Financial Partners LLC boosted its stake in shares of Elevance Health by 2.9% in the third quarter. Catalyst Financial Partners LLC now owns 918 shares of the company’s stock worth $477,000 after buying an additional 26 shares during the last quarter. Finally, Fullcircle Wealth LLC boosted its position in Elevance Health by 1.5% in the 3rd quarter. Fullcircle Wealth LLC now owns 1,743 shares of the company’s stock worth $906,000 after purchasing an additional 26 shares in the last quarter. Hedge funds and other institutional investors own 89.24% of the company’s stock.
Elevance Health Stock Down 0.3 %
Shares of ELV opened at $384.26 on Tuesday. The company’s 50-day moving average price is $388.02 and its 200 day moving average price is $466.18. Elevance Health, Inc. has a 12-month low of $362.21 and a 12-month high of $567.26. The company has a current ratio of 1.50, a quick ratio of 1.50 and a debt-to-equity ratio of 0.56. The firm has a market cap of $89.12 billion, a P/E ratio of 14.01, a price-to-earnings-growth ratio of 1.08 and a beta of 0.84.
Wall Street Analyst Weigh In
Read Our Latest Research Report on ELV
Elevance Health Company Profile
Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.
Read More
- Five stocks we like better than Elevance Health
- What Does Downgrade Mean in Investing?
- Beyond Rigetti: Top 3 Quantum Computing Stock Picks
- What Are Dividend Champions? How to Invest in the Champions
- 3 Dividend Stocks Rewarding Investors With Buybacks
- Technology Stocks Explained: Here’s What to Know About Tech
- Tech Titans in Chips: 3 Semiconductor Stocks Worth Buying Now
Receive News & Ratings for Elevance Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elevance Health and related companies with MarketBeat.com's FREE daily email newsletter.